Literature DB >> 17097615

MNB/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteins.

Tatyana Adayev1, Mo-Chou Chen-Hwang, Noriko Murakami, Rong Wang, Yu-Wen Hwang.   

Abstract

MNB/DYRK1A is a proline-directed serine/threonine kinase implicated in Down syndrome (DS). In an earlier screening, two proteins from adult rat brain, one 100kDa and the other 140 kDa, were found to be prominently phosphorylated by the kinase. The 100-kDa protein was previously characterized as an isoform of dynamin 1. In this study, we identified the 140-kDa protein as synaptojanin 1 (SJ1). MNB/DYRK1A phosphorylates SJ1 at multiple sites and produces complex behaviors in binding to amphiphysin 1 and intersectin 1 (ITSN1). However, the phosphorylation has little effect on the phosphatidylinositol phosphatase activity of SJ1. These results suggest that MNB/DYRK1A is involved in regulating the recruitment activity but not the phosphatase activity of SJ1. Our findings may be especially important in the etiology of DS because MNB/DYRK1A, SJ1, and ITSN1 are all located at or near the region of human chromosome 21, which is postulated to be involved in the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097615      PMCID: PMC1750923          DOI: 10.1016/j.bbrc.2006.10.169

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Dynamin is a minibrain kinase/dual specificity Yak1-related kinase 1A substrate.

Authors:  Mo-Chou Chen-Hwang; Huey-Ru Chen; Marshall Elzinga; Yu-Wen Hwang
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

2.  Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).

Authors:  M S Cheon; S H Kim; V Ovod; N Kopitar Jerala; J I Morgan; Y Hatefi; T Ijuin; T Takenawa; G Lubec
Journal:  Amino Acids       Date:  2003       Impact factor: 3.520

3.  Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from "the Down syndrome critical region" of chromosome 21.

Authors:  N Shindoh; J Kudoh; H Maeda; A Yamaki; S Minoshima; Y Shimizu; N Shimizu
Journal:  Biochem Biophys Res Commun       Date:  1996-08-05       Impact factor: 3.575

4.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

5.  Excessive expression of synaptojanin in brains with Down syndrome.

Authors:  Yasuhiro Arai; Takeshi Ijuin; Tadanomi Takenawa; Laurence E Becker; Sachio Takashima
Journal:  Brain Dev       Date:  2002-03       Impact factor: 1.961

6.  Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system.

Authors:  Eulàlia Martí; Xavier Altafaj; Mara Dierssen; Susana de la Luna; Vassiliki Fotaki; Mónica Alvarez; Mercè Pérez-Riba; Isidro Ferrer; Xavier Estivill
Journal:  Brain Res       Date:  2003-02-28       Impact factor: 3.252

7.  Mnb/Dyrk1A is transiently expressed and asymmetrically segregated in neural progenitor cells at the transition to neurogenic divisions.

Authors:  B Hämmerle; E Vera-Samper; S Speicher; R Arencibia; S Martínez; F J Tejedor
Journal:  Dev Biol       Date:  2002-06-15       Impact factor: 3.582

8.  Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation.

Authors:  B Hämmerle; A Carnicero; C Elizalde; J Ceron; S Martínez; F J Tejedor
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

9.  Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses.

Authors:  Sang Yoon Lee; Markus R Wenk; Yong Kim; Angus C Nairn; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

10.  Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.

Authors:  Vassiliki Fotaki; Mara Dierssen; Soledad Alcántara; Salvador Martínez; Eulàlia Martí; Caty Casas; Joana Visa; Eduardo Soriano; Xavier Estivill; Maria L Arbonés
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more
  21 in total

Review 1.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

2.  Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome.

Authors:  Sergey V Voronov; Samuel G Frere; Silvia Giovedi; Elizabeth A Pollina; Christelle Borel; Hong Zhang; Cecilia Schmidt; Ellen C Akeson; Markus R Wenk; Laurent Cimasoni; Ottavio Arancio; Muriel T Davisson; Stylianos E Antonarakis; Katheleen Gardiner; Pietro De Camilli; Gilbert Di Paolo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

3.  Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease.

Authors:  Sarah B Martin; Amy L S Dowling; Joann Lianekhammy; Ira T Lott; Eric Doran; M Paul Murphy; Tina L Beckett; Frederick A Schmitt; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers.

Authors:  Shanshan Li; Chu Xu; Yinkun Fu; Pin-Ji Lei; Yanhua Yao; Wanli Yang; Ying Zhang; Michael P Washburn; Laurence Florens; Manish Jaiswal; Min Wu; Man Mohan
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

5.  Phosphorylation of Synaptojanin Differentially Regulates Endocytosis of Functionally Distinct Synaptic Vesicle Pools.

Authors:  Junhua Geng; Liping Wang; Joo Yeun Lee; Chun-Kan Chen; Karen T Chang
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

6.  Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes.

Authors:  Jack-Christophe Cossec; Jérémie Lavaur; Diego E Berman; Isabelle Rivals; Alexander Hoischen; Samantha Stora; Clémentine Ripoll; Clotilde Mircher; Yann Grattau; Jean-Christophe Olivomarin; Fabrice de Chaumont; Magalie Lecourtois; Stylianos E Antonarakis; Joris A Veltman; Jean M Delabar; Charles Duyckaerts; Gilbert Di Paolo; Marie-Claude Potier
Journal:  Hum Mol Genet       Date:  2012-04-17       Impact factor: 6.150

7.  DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia.

Authors:  Olga Bogacheva; Oleg Bogachev; Madhu Menon; Arvind Dev; Estelle Houde; Elizabeth I Valoret; Haydn M Prosser; Caretha L Creasy; Susan J Pickering; Evelyn Grau; Kim Rance; George P Livi; Vinit Karur; Connie L Erickson-Miller; Don M Wojchowski
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

8.  Promotion of neuronal plasticity by (-)-epigallocatechin-3-gallate.

Authors:  Wen Xie; Narayan Ramakrishna; Andrzej Wieraszko; Yu-Wen Hwang
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

9.  Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801.

Authors:  A Siddiqui; T Lacroix; M R Stasko; J J Scott-McKean; A C S Costa; K J Gardiner
Journal:  Genes Brain Behav       Date:  2008-10       Impact factor: 3.449

10.  Regulation of synaptojanin 2 5'-phosphatase activity by Src.

Authors:  Yayu Chuang; Xiaonan Xu; Aneta Kwiatkowska; George Tsapraillis; Hyonson Hwang; Konstantinos Petritis; Dan Flynn; Marc Symons
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.